BGB-3245 (Brimarafenib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BGB-3245 (Brimarafenib), covering 2025-04-20 to 2025-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers [Phase 1]